CDDF Multi-stakeholder Workshop on Involving Patients In Oncology Drug Developmen

This multi-stakeholder workshop organized by the Cancer Drug Development Forum will take place in Amsterdam on 18-19 June 2019. It aims at looking at the opportunities and challenges of incorporating the patient-relevant evidence into oncology drug development and approval process from the perspective of patients, health care providers, health authorities, HTA bodies, payers and industry. The workshop will address the following topics:

• Examine the different type of patient-relevant evidence for patient-focused drug development
• Exemplary models for interactions between patients’ communities, sponsors and decision-makers
• Examples of qualitative and quantitative patient-experience data and its contribution to development, review, approval and access to new drugs

TARGET AUDIENCE
The target is a multidisciplinary audience of Patient Associations, Academia Representatives, EU and US Regulatory Bodies (EMA, FDA, National Agencies), Pharmaceutical Industry, and HTAs.

PROGRAMME COMMITTEE

• Academia: Axel Glasmacher (CDDF Board)
• Industry representatives : Claudia Hey (Merck), Elisabeth Piault-Louis (Genentech), Marloes Van Bruggen (Roche)
• Patient Advocates: Francesco De Lorenzo (ECPC, Italy)
• Regulatory Authorities: Ralf Herold (EMA), Belinda King-Kallimanis (FDA)
• HTA bodies: Margarida Oliveira (Infarmed), Giovanni Tafuri (EUnetHTA)

DRAFT PROGRAMME

Please visit the CDDF website for more information.

Others Details

MEETING VENUE Park Hotel Amsterdam Stadhouderskade 25 1071 ZD Amsterdam Netherlands https://www.parkhotelamsterdam.nl/en/